WELCOME TO BILLS BIOTECH PVT. LTD.
Bills Biotech is a research based Biopharmaceutical Company with manufacturing capabilities. Home to an ultramodern fermentation facility and top of the line R&D division. Bills today offers fermentation based APIs. Our product line and research area includes but not limited to biopharmaceuticals (Anti - Obesity, Immunomodulators), Biopharma Intermediates. Actively engaged into contract research and manufacturing of fermentation based products in biopharmaceutical, cosmaceutical and nutraceutical sector.
COMPANY OVERVIEW
Bills Biotech. Is an R&D driven biotechnological company that manufactures Active Pharmaceutical Ingredients through the process of Fermentation, Semi-synthetic and synthetic processes.
The company Established in 2010 and became the first company to be operational in dedicated Biotech Park.
ISO 9001:2008 certified facility was built up as per GMP standards and approved by FDCA.
Manufacturing unit comprise of microbiology, fermentation, downstream processing, crystallization and finished product powder processing area.
Separate testing department, equipped with latest instruments, works under QA/QC which support plant operation on quality control and documentation.
R & D unit comprise of process development laboratory for fermentation, downstream purification, analytical method development, effluent treatment research.
Engineering utility maintenance department and project department to provide 24 X 7 supports to manufacturing plant and R & D activity.
Our passion is to improve and prolong life of people suffering with serious illness. And this is what drives our research and development efforts.
Bills Biotech is at the forefront of commissioning its manufacturing and research and development facilities. In coming months as our R&D division takes shape, we will be engaging in discovering and developing ways to treat and prevent life threatening illness like heart diseases, obesity, challenges associated with organ transplant.
We have an uncompromising attitude for innovation and safety, the two pillars of our research that will deliver the future of medicine we bring. As our Research and Biotechnology units progress their portfolios we make sure they have access to the industry's best supporting scientific services, clinical and development talents.
